UPDATE 1-Fosun Pharma, TPG agree to buy Chindex in sweetened $461 mln deal
April 21, 2014 at 23:55 PM EDT
SHANGHAI, April 21 (Reuters) - Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd and private equity firm TPG Capital agreed to buy China-focused Chindex International Inc in a beefed-up $461 million deal after trumping a rival bid.
